Internal Medicine, Rheumatology · San Francisco, CA
NPI
1780841197
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
505 Parnassus Ave, M-987
San Francisco, CA, 94143
Phone (415) 476-1528
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.7M
2,241 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ann Mary Belek prescribed most often to Medicare patients was Prednisone, with 494 prescriptions and refills. In total Ann Mary Belek wrote 2,241 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 494 | 937 | 178 | $6,127 |
| Methotrexate Methotrexate Sodium | 310 | 834 | 128 | $7,484 |
| Hydroxychloroquine Sulfate Generic | 286 | 885 | 116 | $11K |
| Rasuvo Methotrexate/Pf | 140 | 176 | 24 | $69K |
| Alendronate Sodium Generic | 114 | 315 | 56 | $5,856 |
| Meloxicam Generic | 87 | 270 | 45 | $757 |
| Enbrel Sureclick Etanercept | 76 | 76 | 13 | $446K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 56 | 104 | 21 | $107K |
| Orencia Clickject Abatacept | 56 | 57 | Under 11 | $257K |
| Leflunomide Generic | 54 | 178 | 27 | $1,731 |
| Leucovorin Calcium Generic | 52 | 145 | 22 | $618 |
| Sulfasalazine Generic | 50 | 156 | 23 | $3,558 |
| Colchicine Generic | 46 | 116 | 16 | $1,729 |
| Mycophenolate Mofetil Generic | 38 | 124 | 16 | $5,464 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 36 | 40 | Under 11 | $145K |
Brand drugs: 588 claims; generic drugs: 1,640 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ann Mary Belek were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.